Biographical summary
Konstantinos Leventakos, M.D., is a medical oncologist with a focus on thoracic malignancies, personalized medicine and immunotherapy. His clinical focus includes:
    - Non-small cell lung cancer
- Small cell lung cancer
- Mesothelioma
- Thymic malignancies
- Neuroendocrine tumors
- Multidisciplinary approach to thoracic malignancies and personalized medicine
- Integration of Artificial Intelligence (AI) for clinical trial matching
In addition to his clinical activities, Dr. Leventakos is active in research and education of medical students, residents and Oncology fellows. He publishes in many journals and speaks at many national and international meetings.
        Conditions treated
        
        Interests
- Lung cancer
- Mesothelioma
- Thymoma and thymic cancer
- Neuroendocrine tumors of the lung 
- Individualized medicine
- Artificial intelligence and clinical trial matching
- Immunotherapy
- Early Cancer Therapeutics/Phase 1 Clinical Trials
- Palliative care and symptom control
- Telemedicine in Oncology
Mayo Clinic locations
        Education
- 2017Ph.D.University of Athens Medical School 
- 2017FellowHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine 
- 2014ResidencyGeorgetown University Hospital and Washington Hospital Center 
- 2011ResidencyAttikon University Hospital of Athens 
- 2009Post-doctoral FellowshipUniversity of Texas MD Anderson Cancer Center 
- 2005MDMedical School of University of Crete, Heraklion 
Activities and honors
Certifications
- 2017HematologyAmerican Board of Internal Medicine 
- 2017Medical OncologyAmerican Board of Internal Medicine 
- 2014Internal MedicineAmerican Board of Internal Medicine 
Awards and honors
- 2025Excellence Through Teamwork Award, Thoracic Oncology WorkgroupMayo Clinic Enterprise 
- 2025Excellence Through Teamwork Award, Mayo Clinic Comprehensive Cancer Center Research Transition TeamMayo Clinic Enterprise 
- 2024Certificate of AppreciationMayo Clinic Comprehensive Cancer Center 
- 2024Award of Excellence for Being the Top Clinical Trial Accruing Provider in the Lung Disease GroupComprehensive Cancer Center; Lung Disease Group 
- 2022Teacher of the YearMayo Clinic Rochester Hematology/Oncology Fellows 
- 20222022 IASLC Academy MemberInternational Association for the Study of Lung Cancer (IASLC) 
- 202140 Early Career Leaders in Oncology Under Age 4040 Under 40 
- 2017Tow Shung Tan Humanism in Medicine Award Mayo Clinic 
- 2017Travel grant to participate in 17th Annual Targeted Therapies of Lung Cancer Meeting, Santa Monica, CA, February, 2017International Association for the Study of Lung Cancer (IASLC)  
- 2017Travel Grant to represent NANETS at the 14th Annual European Neuroendocrine Tumor Society (ENETS) Conference, 3/8-10 2017 in Barcelona, SpainNorth American Neuroendocrine Tumor Society (NANETS) 
- 2016ASCO Ambassadorship to represent ASCO to the Workshop on Methods in Clinical Cancer Research, held in Zeist, Netherlands, June 2016ASCO Ambassadorship 
- 2016Rising Star in OncologySociety of Translational Oncology 
- 2016Travel Grant for the 2016 NANETS symposium in Jackson, Wyoming 9/30 – 10/1, 2016North American Neuroendocrine Tumor Society (NANETS) 
- 2016Support to participate in the  Workshop on Methods in Clinical Cancer Research, held in Zeist, Netherlands. AACR, ECCO, EORTC, ESMOAmerican Association for Cancer Research 
- 2015Travel grant to participate in the 2015 ESMO Preceptorship on Immuno-OncologyEuropean Society of Medical Oncology 
- 2009"The 2009 Kimberly Patterson Fellowship in Leukemia Research Award" for excellence in translational and clinical researchUniversity of Texas System 
- 2005Scholarship for attending the ESO Oncology Course for Medical StudentsEuropean School of Oncology 
- 2004Scholarship for one-month observership in St. Elizabeth’s Medical Center of Boston, Medical School of University of Crete and Tufts University School of Medicine student exchange programStudent Exchange Program  
Professional memberships
- 2026 - presentReview CommitteeAbstract Review Committee, National Comprehensive Cancer Network (NCCN) 
- 2025 - presentMemberAmerican Society for Clinical Oncology (ASCO), State Affiliate Council 
- 2024 - presentResearch Partner Principal InvestigatorMinnesota Cancer Clinical Trials Network (MNCCTN) 
- 2024 - presentPresidentMinnesota Society of Clinical Oncology (MSCO) 
- 2023 - presentAI & I / Innovation Practice & Research ChairDepartment of Oncology Research Committee 
- 2023 - presentLead PhysicianClinical Trial Matching and Feasibility Project Committee 
- 2021Residency Applicant InterviewerDepartment of Internal Medicine, Mayo Clinic, Mayo Clinic Enterprise 
- 2021 - 2023Board Member, Board of DirectorsMinnesota Society of Clinical Oncology (MSCO) 
- 2020 - presentCo-LeaderMayo Clinic, Division of Medical Oncology, Transform the Practice - Streamlined Access to Clinical Trials 
- 2020 - presentMemberScientific Review Committee B 
- 2020 - presentMemberMayo Clinic, Division of Medical Oncology, Junior Faculty Career Development Committee 
- 2020 - presentMemberMayo Clinic Division of Medical Oncology Education Committee 
- 2020 - presentMemberMayo Clinic Internal Medicine Board Review 
- 2019 - presentMemberMayo Clinic Cancer Center, Early Cancer Therapeutics Disease Group 
- 2019 - presentMemberMayo Clinic Cancer Center, Thoracic (Lung) Disease Group 
- 2019 - presentMemberMayo Clinic, Division of Medical Oncology, Wellness Committee 
- 2019 - presentMemberWatson CTM Project Management Team 
- 2019 - presentMemberACCRU Scientific and Administrative Review Committee (SARC) 
- 2015 - presentMemberAmerican Association of Cancer Research 
- 2014 - presentMemberEuropean Society for Medical Oncology 
- 2014 - presentMemberAmerican Society of Clinical Oncology 
- 2014 - presentMemberInternational Association of the Study of Lung Cancer 
Publications